Please Wait

Applying Filters...

Calcipotriol
USDMF
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Calcipotriol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 20 USDMF, 11 CEP/COS, 1 KDMF, 14 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

16 Drugs in Development

16 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 23 FDA Orange Book, 55 Europe, 23 Canada, 7 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 DKSH, 4 Nanjing Well Pharmaceutical, 3 Actylis, 12 BASF, 1 Corel Pharma Chem, 2 Finar, 1 Kerry, 1 Pluviaendo, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

19 Topical, 7 Solubilizers, 6 Parenteral, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 3 Lubricants & Glidants, 2 Controlled & Modified Release, 2 Granulation, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Surfactant & Foaming Agents, 1 Coating Systems & Additives

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 54 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	TAPI Technology & API Services	Israel	TEVA PHARMACEUTICAL INDUSTRIES LTD	16958	CALCIPOTRIENE USP	2003-11-14	Active	II	Complete	2012-11-30	2012-11-13
28/03/2025	ALP Pharm	China	ALP PHARM BEIJING CO LTD	27222	CALCIPOTRIENE HYDRATE	2013-09-06	Active	II	N/A

Contact us
to update this info

Calcipotriol

Calcipotriol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

20 USDMF

11 CEP/COS

1 KDMF

14 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

16 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

23 FDA Orange Book

55 Europe

23 Canada

7 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 DKSH

4 Nanjing Well Pharmaceutical

3 Actylis

12 BASF

1 Corel Pharma Chem

2 Finar

1 Kerry

1 Pluviaendo

1 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

19 Topical

7 Solubilizers

6 Parenteral

4 Film Formers & Plasticizers

4 Emulsifying Agents

4 Thickeners and Stabilizers

3 Lubricants & Glidants

2 Controlled & Modified Release

2 Granulation

2 Direct Compression

1 Fillers, Diluents & Binders

1 Surfactant & Foaming Agents

1 Coating Systems & Additives

DIGITAL CONTENT

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

54 Regulatory FDF Prices

7 Annual Reports

MARKET PLACE

10 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

2 USP

1 Others

Filters

SOLUTION;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons